[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biodegradable Hemostatic Agent Market Insights, Forecast to 2029

December 2023 | 112 pages | ID: G0A8D51D4A40EN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents an overview of global market for Biodegradable Hemostatic Agent market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Biodegradable Hemostatic Agent, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biodegradable Hemostatic Agent, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biodegradable Hemostatic Agent revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Biodegradable Hemostatic Agent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Biodegradable Hemostatic Agent revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences and Zhonghui Shengxi, etc.

By Company
  • Johnson & Johnson
  • BD
  • Baxter
  • B.Braun
  • Cura Medical
  • GELITA MEDICAL
  • Curasan AG
  • Meril Life Sciences
  • Zhonghui Shengxi
  • Beijing Datsing Bio-tech
  • Guizhou Jin Jiu Biotech
  • Beijing Taikesiman
  • Foryou Medical
  • Saikesaisi Holdings Group
  • Biotemed
Segment by Type
  • Gauze
  • Powder
  • Gelatin Sponge
  • Other
Segment by Application
  • Hospital
  • Clinics
  • Others
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East, Africa, and Latin America
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Biodegradable Hemostatic Agent in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biodegradable Hemostatic Agent companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biodegradable Hemostatic Agent revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Biodegradable Hemostatic Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  1.2.2 Gauze
  1.2.3 Powder
  1.2.4 Gelatin Sponge
  1.2.5 Other
1.3 Market by Application
  1.3.1 Global Biodegradable Hemostatic Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  1.3.2 Hospital
  1.3.3 Clinics
  1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Biodegradable Hemostatic Agent Market Perspective (2018-2029)
2.2 Global Biodegradable Hemostatic Agent Growth Trends by Region
  2.2.1 Biodegradable Hemostatic Agent Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Biodegradable Hemostatic Agent Historic Market Size by Region (2018-2023)
  2.2.3 Biodegradable Hemostatic Agent Forecasted Market Size by Region (2024-2029)
2.3 Biodegradable Hemostatic Agent Market Dynamics
  2.3.1 Biodegradable Hemostatic Agent Industry Trends
  2.3.2 Biodegradable Hemostatic Agent Market Drivers
  2.3.3 Biodegradable Hemostatic Agent Market Challenges
  2.3.4 Biodegradable Hemostatic Agent Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Revenue Biodegradable Hemostatic Agent by Players
  3.1.1 Global Biodegradable Hemostatic Agent Revenue by Players (2018-2023)
  3.1.2 Global Biodegradable Hemostatic Agent Revenue Market Share by Players (2018-2023)
3.2 Global Biodegradable Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biodegradable Hemostatic Agent, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Biodegradable Hemostatic Agent Market Concentration Ratio
  3.4.1 Global Biodegradable Hemostatic Agent Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Biodegradable Hemostatic Agent Revenue in 2022
3.5 Global Key Players of Biodegradable Hemostatic Agent Head office and Area Served
3.6 Global Key Players of Biodegradable Hemostatic Agent, Product and Application
3.7 Global Key Players of Biodegradable Hemostatic Agent, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 BIODEGRADABLE HEMOSTATIC AGENT BREAKDOWN DATA BY TYPE

4.1 Global Biodegradable Hemostatic Agent Historic Market Size by Type (2018-2023)
4.2 Global Biodegradable Hemostatic Agent Forecasted Market Size by Type (2024-2029)

5 BIODEGRADABLE HEMOSTATIC AGENT BREAKDOWN DATA BY APPLICATION

5.1 Global Biodegradable Hemostatic Agent Historic Market Size by Application (2018-2023)
5.2 Global Biodegradable Hemostatic Agent Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Biodegradable Hemostatic Agent Market Size (2018-2029)
6.2 North America Biodegradable Hemostatic Agent Market Size by Type
  6.2.1 North America Biodegradable Hemostatic Agent Market Size by Type (2018-2023)
  6.2.2 North America Biodegradable Hemostatic Agent Market Size by Type (2024-2029)
  6.2.3 North America Biodegradable Hemostatic Agent Market Share by Type (2018-2029)
6.3 North America Biodegradable Hemostatic Agent Market Size by Application
  6.3.1 North America Biodegradable Hemostatic Agent Market Size by Application (2018-2023)
  6.3.2 North America Biodegradable Hemostatic Agent Market Size by Application (2024-2029)
  6.3.3 North America Biodegradable Hemostatic Agent Market Share by Application (2018-2029)
6.4 North America Biodegradable Hemostatic Agent Market Size by Country
  6.4.1 North America Biodegradable Hemostatic Agent Market Size by Country: 2018 VS 2022 VS 2029
  6.4.2 North America Biodegradable Hemostatic Agent Market Size by Country (2018-2023)
  6.4.3 North America Biodegradable Hemostatic Agent Market Size by Country (2024-2029)
  6.4.4 United States
  6.4.5 Canada

7 EUROPE

7.1 Europe Biodegradable Hemostatic Agent Market Size (2018-2029)
7.2 Europe Biodegradable Hemostatic Agent Market Size by Type
  7.2.1 Europe Biodegradable Hemostatic Agent Market Size by Type (2018-2023)
  7.2.2 Europe Biodegradable Hemostatic Agent Market Size by Type (2024-2029)
  7.2.3 Europe Biodegradable Hemostatic Agent Market Share by Type (2018-2029)
7.3 Europe Biodegradable Hemostatic Agent Market Size by Application
  7.3.1 Europe Biodegradable Hemostatic Agent Market Size by Application (2018-2023)
  7.3.2 Europe Biodegradable Hemostatic Agent Market Size by Application (2024-2029)
  7.3.3 Europe Biodegradable Hemostatic Agent Market Share by Application (2018-2029)
7.4 Europe Biodegradable Hemostatic Agent Market Size by Country
  7.4.1 Europe Biodegradable Hemostatic Agent Market Size by Country: 2018 VS 2022 VS 2029
  7.4.2 Europe Biodegradable Hemostatic Agent Market Size by Country (2018-2023)
  7.4.3 Europe Biodegradable Hemostatic Agent Market Size by Country (2024-2029)
  7.4.3 Germany
  7.4.4 France
  7.4.5 U.K.
  7.4.6 Italy
  7.4.7 Russia
  7.4.8 Nordic Countries

8 CHINA

8.1 China Biodegradable Hemostatic Agent Market Size (2018-2029)
8.2 China Biodegradable Hemostatic Agent Market Size by Type
  8.2.1 China Biodegradable Hemostatic Agent Market Size by Type (2018-2023)
  8.2.2 China Biodegradable Hemostatic Agent Market Size by Type (2024-2029)
  8.2.3 China Biodegradable Hemostatic Agent Market Share by Type (2018-2029)
8.3 China Biodegradable Hemostatic Agent Market Size by Application
  8.3.1 China Biodegradable Hemostatic Agent Market Size by Application (2018-2023)
  8.3.2 China Biodegradable Hemostatic Agent Market Size by Application (2024-2029)
  8.3.3 China Biodegradable Hemostatic Agent Market Share by Application (2018-2029)

9 ASIA (EXCLUDING CHINA)

9.1 Asia Biodegradable Hemostatic Agent Market Size (2018-2029)
9.2 Asia Biodegradable Hemostatic Agent Market Size by Type
  9.2.1 Asia Biodegradable Hemostatic Agent Market Size by Type (2018-2023)
  9.2.2 Asia Biodegradable Hemostatic Agent Market Size by Type (2024-2029)
  9.2.3 Asia Biodegradable Hemostatic Agent Market Share by Type (2018-2029)
9.3 Asia Biodegradable Hemostatic Agent Market Size by Application
  9.3.1 Asia Biodegradable Hemostatic Agent Market Size by Application (2018-2023)
  9.3.2 Asia Biodegradable Hemostatic Agent Market Size by Application (2024-2029)
  9.3.3 Asia Biodegradable Hemostatic Agent Market Share by Application (2018-2029)
9.4 Asia Biodegradable Hemostatic Agent Market Size by Region
  9.4.1 Asia Biodegradable Hemostatic Agent Market Size by Region: 2018 VS 2022 VS 2029
  9.4.2 Asia Biodegradable Hemostatic Agent Market Size by Region (2018-2023)
  9.4.3 Asia Biodegradable Hemostatic Agent Market Size by Region (2024-2029)
  9.4.4 Japan
  9.4.5 South Korea
  9.4.6 China Taiwan
  9.4.7 Southeast Asia
  9.4.8 India
  9.4.9 Australia

10 MIDDLE EAST, AFRICA, AND LATIN AMERICA

10.1 Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Type
  10.2.1 Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Type (2018-2023)
  10.2.2 Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Type (2024-2029)
  10.2.3 Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Application
  10.3.1 Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Application (2018-2023)
  10.3.2 Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Application (2024-2029)
  10.3.3 Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Country
  10.4.1 Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Country: 2018 VS 2022 VS 2029
  10.4.2 Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Country (2018-2023)
  10.4.3 Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Country (2024-2029)
  10.4.4 Brazil
  10.4.5 Mexico
  10.4.6 Turkey
  10.4.7 Saudi Arabia
  10.4.8 Israel
  10.4.9 GCC Countries

11 KEY PLAYERS PROFILES

11.1 Johnson & Johnson
  11.1.1 Johnson & Johnson Company Details
  11.1.2 Johnson & Johnson Business Overview
  11.1.3 Johnson & Johnson Biodegradable Hemostatic Agent Introduction
  11.1.4 Johnson & Johnson Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.1.5 Johnson & Johnson Recent Developments
11.2 BD
  11.2.1 BD Company Details
  11.2.2 BD Business Overview
  11.2.3 BD Biodegradable Hemostatic Agent Introduction
  11.2.4 BD Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.2.5 BD Recent Developments
11.3 Baxter
  11.3.1 Baxter Company Details
  11.3.2 Baxter Business Overview
  11.3.3 Baxter Biodegradable Hemostatic Agent Introduction
  11.3.4 Baxter Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.3.5 Baxter Recent Developments
11.4 B.Braun
  11.4.1 B.Braun Company Details
  11.4.2 B.Braun Business Overview
  11.4.3 B.Braun Biodegradable Hemostatic Agent Introduction
  11.4.4 B.Braun Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.4.5 B.Braun Recent Developments
11.5 Cura Medical
  11.5.1 Cura Medical Company Details
  11.5.2 Cura Medical Business Overview
  11.5.3 Cura Medical Biodegradable Hemostatic Agent Introduction
  11.5.4 Cura Medical Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.5.5 Cura Medical Recent Developments
11.6 GELITA MEDICAL
  11.6.1 GELITA MEDICAL Company Details
  11.6.2 GELITA MEDICAL Business Overview
  11.6.3 GELITA MEDICAL Biodegradable Hemostatic Agent Introduction
  11.6.4 GELITA MEDICAL Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.6.5 GELITA MEDICAL Recent Developments
11.7 Curasan AG
  11.7.1 Curasan AG Company Details
  11.7.2 Curasan AG Business Overview
  11.7.3 Curasan AG Biodegradable Hemostatic Agent Introduction
  11.7.4 Curasan AG Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.7.5 Curasan AG Recent Developments
11.8 Meril Life Sciences
  11.8.1 Meril Life Sciences Company Details
  11.8.2 Meril Life Sciences Business Overview
  11.8.3 Meril Life Sciences Biodegradable Hemostatic Agent Introduction
  11.8.4 Meril Life Sciences Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.8.5 Meril Life Sciences Recent Developments
11.9 Zhonghui Shengxi
  11.9.1 Zhonghui Shengxi Company Details
  11.9.2 Zhonghui Shengxi Business Overview
  11.9.3 Zhonghui Shengxi Biodegradable Hemostatic Agent Introduction
  11.9.4 Zhonghui Shengxi Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.9.5 Zhonghui Shengxi Recent Developments
11.10 Beijing Datsing Bio-tech
  11.10.1 Beijing Datsing Bio-tech Company Details
  11.10.2 Beijing Datsing Bio-tech Business Overview
  11.10.3 Beijing Datsing Bio-tech Biodegradable Hemostatic Agent Introduction
  11.10.4 Beijing Datsing Bio-tech Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.10.5 Beijing Datsing Bio-tech Recent Developments
11.11 Guizhou Jin Jiu Biotech
  11.11.1 Guizhou Jin Jiu Biotech Company Details
  11.11.2 Guizhou Jin Jiu Biotech Business Overview
  11.11.3 Guizhou Jin Jiu Biotech Biodegradable Hemostatic Agent Introduction
  11.11.4 Guizhou Jin Jiu Biotech Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.11.5 Guizhou Jin Jiu Biotech Recent Developments
11.12 Beijing Taikesiman
  11.12.1 Beijing Taikesiman Company Details
  11.12.2 Beijing Taikesiman Business Overview
  11.12.3 Beijing Taikesiman Biodegradable Hemostatic Agent Introduction
  11.12.4 Beijing Taikesiman Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.12.5 Beijing Taikesiman Recent Developments
11.13 Foryou Medical
  11.13.1 Foryou Medical Company Details
  11.13.2 Foryou Medical Business Overview
  11.13.3 Foryou Medical Biodegradable Hemostatic Agent Introduction
  11.13.4 Foryou Medical Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.13.5 Foryou Medical Recent Developments
11.14 Saikesaisi Holdings Group
  11.14.1 Saikesaisi Holdings Group Company Details
  11.14.2 Saikesaisi Holdings Group Business Overview
  11.14.3 Saikesaisi Holdings Group Biodegradable Hemostatic Agent Introduction
  11.14.4 Saikesaisi Holdings Group Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.14.5 Saikesaisi Holdings Group Recent Developments
11.15 Biotemed
  11.15.1 Biotemed Company Details
  11.15.2 Biotemed Business Overview
  11.15.3 Biotemed Biodegradable Hemostatic Agent Introduction
  11.15.4 Biotemed Revenue in Biodegradable Hemostatic Agent Business (2018-2023)
  11.15.5 Biotemed Recent Developments

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES

Table 1. Global Biodegradable Hemostatic Agent Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Gauze
Table 3. Key Players of Powder
Table 4. Key Players of Gelatin Sponge
Table 5. Key Players of Other
Table 6. Global Biodegradable Hemostatic Agent Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Biodegradable Hemostatic Agent Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Biodegradable Hemostatic Agent Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Biodegradable Hemostatic Agent Market Share by Region (2018-2023)
Table 10. Global Biodegradable Hemostatic Agent Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Biodegradable Hemostatic Agent Market Share by Region (2024-2029)
Table 12. Biodegradable Hemostatic Agent Market Trends
Table 13. Biodegradable Hemostatic Agent Market Drivers
Table 14. Biodegradable Hemostatic Agent Market Challenges
Table 15. Biodegradable Hemostatic Agent Market Restraints
Table 16. Global Biodegradable Hemostatic Agent Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Biodegradable Hemostatic Agent Revenue Share by Players (2018-2023)
Table 18. Global Top Biodegradable Hemostatic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodegradable Hemostatic Agent as of 2022)
Table 19. Global Biodegradable Hemostatic Agent Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Biodegradable Hemostatic Agent Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Biodegradable Hemostatic Agent, Headquarters and Area Served
Table 22. Global Key Players of Biodegradable Hemostatic Agent, Product and Application
Table 23. Global Key Players of Biodegradable Hemostatic Agent, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biodegradable Hemostatic Agent Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Biodegradable Hemostatic Agent Revenue Market Share by Type (2018-2023)
Table 27. Global Biodegradable Hemostatic Agent Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Biodegradable Hemostatic Agent Revenue Market Share by Type (2024-2029)
Table 29. Global Biodegradable Hemostatic Agent Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Biodegradable Hemostatic Agent Revenue Share by Application (2018-2023)
Table 31. Global Biodegradable Hemostatic Agent Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Biodegradable Hemostatic Agent Revenue Share by Application (2024-2029)
Table 33. North America Biodegradable Hemostatic Agent Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Biodegradable Hemostatic Agent Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Biodegradable Hemostatic Agent Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Biodegradable Hemostatic Agent Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Biodegradable Hemostatic Agent Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Biodegradable Hemostatic Agent Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Biodegradable Hemostatic Agent Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Biodegradable Hemostatic Agent Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Biodegradable Hemostatic Agent Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Biodegradable Hemostatic Agent Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Biodegradable Hemostatic Agent Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Biodegradable Hemostatic Agent Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Biodegradable Hemostatic Agent Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Biodegradable Hemostatic Agent Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Biodegradable Hemostatic Agent Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Biodegradable Hemostatic Agent Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Biodegradable Hemostatic Agent Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Biodegradable Hemostatic Agent Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Biodegradable Hemostatic Agent Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Biodegradable Hemostatic Agent Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Biodegradable Hemostatic Agent Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Biodegradable Hemostatic Agent Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Biodegradable Hemostatic Agent Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Biodegradable Hemostatic Agent Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Biodegradable Hemostatic Agent Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size by Country (2024-2029) & (US$ Million)
Table 65. Johnson & Johnson Company Details
Table 66. Johnson & Johnson Business Overview
Table 67. Johnson & Johnson Biodegradable Hemostatic Agent Product
Table 68. Johnson & Johnson Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 69. Johnson & Johnson Recent Developments
Table 70. BD Company Details
Table 71. BD Business Overview
Table 72. BD Biodegradable Hemostatic Agent Product
Table 73. BD Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 74. BD Recent Developments
Table 75. Baxter Company Details
Table 76. Baxter Business Overview
Table 77. Baxter Biodegradable Hemostatic Agent Product
Table 78. Baxter Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 79. Baxter Recent Developments
Table 80. B.Braun Company Details
Table 81. B.Braun Business Overview
Table 82. B.Braun Biodegradable Hemostatic Agent Product
Table 83. B.Braun Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 84. B.Braun Recent Developments
Table 85. Cura Medical Company Details
Table 86. Cura Medical Business Overview
Table 87. Cura Medical Biodegradable Hemostatic Agent Product
Table 88. Cura Medical Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 89. Cura Medical Recent Developments
Table 90. GELITA MEDICAL Company Details
Table 91. GELITA MEDICAL Business Overview
Table 92. GELITA MEDICAL Biodegradable Hemostatic Agent Product
Table 93. GELITA MEDICAL Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 94. GELITA MEDICAL Recent Developments
Table 95. Curasan AG Company Details
Table 96. Curasan AG Business Overview
Table 97. Curasan AG Biodegradable Hemostatic Agent Product
Table 98. Curasan AG Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 99. Curasan AG Recent Developments
Table 100. Meril Life Sciences Company Details
Table 101. Meril Life Sciences Business Overview
Table 102. Meril Life Sciences Biodegradable Hemostatic Agent Product
Table 103. Meril Life Sciences Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 104. Meril Life Sciences Recent Developments
Table 105. Zhonghui Shengxi Company Details
Table 106. Zhonghui Shengxi Business Overview
Table 107. Zhonghui Shengxi Biodegradable Hemostatic Agent Product
Table 108. Zhonghui Shengxi Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 109. Zhonghui Shengxi Recent Developments
Table 110. Beijing Datsing Bio-tech Company Details
Table 111. Beijing Datsing Bio-tech Business Overview
Table 112. Beijing Datsing Bio-tech Biodegradable Hemostatic Agent Product
Table 113. Beijing Datsing Bio-tech Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 114. Beijing Datsing Bio-tech Recent Developments
Table 115. Guizhou Jin Jiu Biotech Company Details
Table 116. Guizhou Jin Jiu Biotech Business Overview
Table 117. Guizhou Jin Jiu Biotech Biodegradable Hemostatic Agent Product
Table 118. Guizhou Jin Jiu Biotech Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 119. Guizhou Jin Jiu Biotech Recent Developments
Table 120. Beijing Taikesiman Company Details
Table 121. Beijing Taikesiman Business Overview
Table 122. Beijing Taikesiman Biodegradable Hemostatic Agent Product
Table 123. Beijing Taikesiman Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 124. Beijing Taikesiman Recent Developments
Table 125. Foryou Medical Company Details
Table 126. Foryou Medical Business Overview
Table 127. Foryou Medical Biodegradable Hemostatic Agent Product
Table 128. Foryou Medical Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 129. Foryou Medical Recent Developments
Table 130. Saikesaisi Holdings Group Company Details
Table 131. Saikesaisi Holdings Group Business Overview
Table 132. Saikesaisi Holdings Group Biodegradable Hemostatic Agent Product
Table 133. Saikesaisi Holdings Group Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 134. Saikesaisi Holdings Group Recent Developments
Table 135. Biotemed Company Details
Table 136. Biotemed Business Overview
Table 137. Biotemed Biodegradable Hemostatic Agent Product
Table 138. Biotemed Revenue in Biodegradable Hemostatic Agent Business (2018-2023) & (US$ Million)
Table 139. Biotemed Recent Developments
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Biodegradable Hemostatic Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Biodegradable Hemostatic Agent Market Share by Type: 2022 VS 2029
Figure 3. Gauze Features
Figure 4. Powder Features
Figure 5. Gelatin Sponge Features
Figure 6. Other Features
Figure 7. Global Biodegradable Hemostatic Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Biodegradable Hemostatic Agent Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Biodegradable Hemostatic Agent Report Years Considered
Figure 13. Global Biodegradable Hemostatic Agent Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Biodegradable Hemostatic Agent Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Biodegradable Hemostatic Agent Market Share by Region: 2022 VS 2029
Figure 16. Global Biodegradable Hemostatic Agent Market Share by Players in 2022
Figure 17. Global Top Biodegradable Hemostatic Agent Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodegradable Hemostatic Agent as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Biodegradable Hemostatic Agent Revenue in 2022
Figure 19. North America Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Biodegradable Hemostatic Agent Market Share by Type (2018-2029)
Figure 21. North America Biodegradable Hemostatic Agent Market Share by Application (2018-2029)
Figure 22. North America Biodegradable Hemostatic Agent Market Share by Country (2018-2029)
Figure 23. United States Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Biodegradable Hemostatic Agent Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Biodegradable Hemostatic Agent Market Share by Type (2018-2029)
Figure 27. Europe Biodegradable Hemostatic Agent Market Share by Application (2018-2029)
Figure 28. Europe Biodegradable Hemostatic Agent Market Share by Country (2018-2029)
Figure 29. Germany Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Biodegradable Hemostatic Agent Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Biodegradable Hemostatic Agent Market Share by Type (2018-2029)
Figure 37. China Biodegradable Hemostatic Agent Market Share by Application (2018-2029)
Figure 38. Asia Biodegradable Hemostatic Agent Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Biodegradable Hemostatic Agent Market Share by Type (2018-2029)
Figure 40. Asia Biodegradable Hemostatic Agent Market Share by Application (2018-2029)
Figure 41. Asia Biodegradable Hemostatic Agent Market Share by Region (2018-2029)
Figure 42. Japan Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Biodegradable Hemostatic Agent Market Share by Country (2018-2029)
Figure 52. Brazil Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Biodegradable Hemostatic Agent Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Johnson & Johnson Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 59. BD Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 60. Baxter Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 61. B.Braun Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 62. Cura Medical Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 63. GELITA MEDICAL Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 64. Curasan AG Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 65. Meril Life Sciences Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 66. Zhonghui Shengxi Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 67. Beijing Datsing Bio-tech Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 68. Guizhou Jin Jiu Biotech Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 69. Beijing Taikesiman Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 70. Foryou Medical Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 71. Saikesaisi Holdings Group Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 72. Biotemed Revenue Growth Rate in Biodegradable Hemostatic Agent Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed


More Publications